Lorraine Pamela D'Alessio
CIK: 0001905593
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MGRX
MANGOCEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About D'Alessio Lorraine Pamela
D'Alessio Lorraine Pamela (SEC CIK 0001905593) files insider reports with the SEC as Director of MANGOCEUTICALS, INC. (MGRX).
Signal8 holds 2 ownership filings by D'Alessio Lorraine Pamela, all Form 4s, filed between Apr 11, 2025 and Sep 12, 2025. Those filings report 2 transactions, from Apr 10, 2025 to Sep 9, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on D'Alessio Lorraine Pamela's filings is in DALLAS, TX.
Recent filings by D'Alessio Lorraine Pamela
Other insiders filing for MANGOCEUTICALS, INC. (MGRX)
- Cohen Jacob D., Chief Executive Officer
- JOHNSTON EUGENE M, CFO
- Hamilton Alex P., Director
- MYERS KENNY, Director
- Isaac Antonios, President